查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413102

自然殺手細胞療法市場：按治療方法、方法、應用和最終用戶 - 2024-2030 年全球預測

Natural Killer Cell Therapeutics Market by Therapeutics (NK Cell Directed Antibodies, NK Cell Therapies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

自然殺手細胞療法市場規模預計2023年為53.1億美元，預計2024年將達60.2億美元，2030年將達到117.1億美元，複合年成長率為11.94%，預計。

自然殺手細胞治療藥物的全球市場

主要市場統計
基準年[2023] 53.1億美元
預測年份 [2024] 60.2億美元
預測年份 [2030] 117.1億美元
複合年成長率（%） 11.94%
自然殺手細胞治療藥物市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估自然殺手細胞治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對自然殺手細胞治療藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-自然殺手細胞治療市場的市場規模與預測是多少？

2-自然殺手細胞治療藥物市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-自然殺手細胞治療藥物市場的技術趨勢和法律規範是什麼？

4-自然殺手細胞治療藥物市場主要供應商的市場佔有率是多少？

5-進入自然殺手細胞治療市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地癌症盛行率上升
      • 副作用最小的標靶治療趨勢
      • 免疫療法的顯著改進
    • 抑制因素
      • 自然殺手細胞治療藥物的高成本
    • 機會
      • 持續研究和開發以改進自然殺手細胞療法
      • 自然殺手細胞治療新藥研發的優勢投資
    • 任務
      • 與自然殺手細胞治療藥物相關的複雜性
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章自然殺手細胞治療藥物市場（依 Therapeutics 分類）

  • NK細胞定向抗體
  • NK細胞療法

第7章自然殺手細胞治療藥物市場分析

  • 抗體依賴性細胞介導的細胞毒性（ADCC）
  • 雙特異性抗體

第8章自然殺手細胞治療藥物市場：依應用分類

  • 急性感染疾病
  • 癌症
  • 消化系統疾病
  • 免疫增生性疾病

第9章自然殺手細胞治療藥物市場：依最終使用者分類

  • 醫院
  • 研究和學術機構
  • 專科診所

第10章美洲自然殺手細胞治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區自然殺手細胞治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲自然殺手細胞治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Acepodia Inc.
    • Affimed NV
    • BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc.
    • Celgene Corporation by Bristol-Myers Squibb Company
    • Celularity Inc.
    • Century Therapeutics, Inc.
    • Cytovac A/S
    • Dragonfly Therapeutics, Inc.
    • EMERcell
    • Fate Therapeutics, Inc.
    • Fortress Biotech, Inc.
    • Gamida Cell Ltd.
    • Glycostem Therapeutics BV
    • iCell Gene Therapeutics LLC
    • ImmunityBio, Inc. by NantWorks LLC
    • Innate Pharma SA
    • Kiadis Pharma NV by Sanofi SA
    • Merck KGaA
    • MiNK Therapeutics, Inc.
    • Multimmune GmbH
    • Nkarta, Inc.
    • PersonGen BioTherapeutics
    • Phio Pharmaceuticals Inc.
    • Regeneron Pharmaceuticals Inc.
    • Takeda Pharmaceutical Company Limited
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-5C6F41F5B003

[184 Pages Report] The Natural Killer Cell Therapeutics Market size was estimated at USD 5.31 billion in 2023 and expected to reach USD 6.02 billion in 2024, at a CAGR 11.94% to reach USD 11.71 billion by 2030.

Global Natural Killer Cell Therapeutics Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.31 billion
Estimated Year [2024] USD 6.02 billion
Forecast Year [2030] USD 11.71 billion
CAGR (%) 11.94%
Natural Killer Cell Therapeutics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Natural Killer Cell Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Natural Killer Cell Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Natural Killer Cell Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Acepodia Inc., Affimed N.V., BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc., Celgene Corporation by Bristol-Myers Squibb Company, Celularity Inc., Century Therapeutics, Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., EMERcell, Fate Therapeutics, Inc., Fortress Biotech, Inc., Gamida Cell Ltd., Glycostem Therapeutics B.V., iCell Gene Therapeutics LLC, ImmunityBio, Inc. by NantWorks LLC, Innate Pharma S.A., Kiadis Pharma N.V. by Sanofi S.A., Merck KGaA, MiNK Therapeutics, Inc., Multimmune GmbH, Nkarta, Inc., PersonGen BioTherapeutics, Phio Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Natural Killer Cell Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapeutics
    • NK Cell Directed Antibodies
    • NK Cell Therapies
  • Approaches
    • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
    • Bispecific Antibodies
  • Application
    • Acute Infectious Diseases
    • Cancer
    • Gastrointestinal Diseases
    • Immunoproliferative Disorders
  • End User
    • Hospitals
    • Research & Academic Institutes
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Natural Killer Cell Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Natural Killer Cell Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Natural Killer Cell Therapeutics Market?

4. What is the market share of the leading vendors in the Natural Killer Cell Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Natural Killer Cell Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Natural Killer Cell Therapeutics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer worldwide
      • 5.1.1.2. Inclination towards targeted therapies with minimal side effects
      • 5.1.1.3. Significant improvements in immunotherapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with natural killer cell therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D to improve natural killer cell therapeutics
      • 5.1.3.2. Favorable investments for development of novel natural killer cell therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity associated with natural killer cell therapeutics
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Natural Killer Cell Therapeutics Market, by Therapeutics

  • 6.1. Introduction
  • 6.2. NK Cell Directed Antibodies
  • 6.3. NK Cell Therapies

7. Natural Killer Cell Therapeutics Market, by Approaches

  • 7.1. Introduction
  • 7.2. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
  • 7.3. Bispecific Antibodies

8. Natural Killer Cell Therapeutics Market, by Application

  • 8.1. Introduction
  • 8.2. Acute Infectious Diseases
  • 8.3. Cancer
  • 8.4. Gastrointestinal Diseases
  • 8.5. Immunoproliferative Disorders

9. Natural Killer Cell Therapeutics Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Research & Academic Institutes
  • 9.4. Specialty Clinics

10. Americas Natural Killer Cell Therapeutics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Natural Killer Cell Therapeutics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Natural Killer Cell Therapeutics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Acepodia Inc.
    • 14.1.2. Affimed N.V.
    • 14.1.3. BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc.
    • 14.1.4. Celgene Corporation by Bristol-Myers Squibb Company
    • 14.1.5. Celularity Inc.
    • 14.1.6. Century Therapeutics, Inc.
    • 14.1.7. Cytovac A/S
    • 14.1.8. Dragonfly Therapeutics, Inc.
    • 14.1.9. EMERcell
    • 14.1.10. Fate Therapeutics, Inc.
    • 14.1.11. Fortress Biotech, Inc.
    • 14.1.12. Gamida Cell Ltd.
    • 14.1.13. Glycostem Therapeutics B.V.
    • 14.1.14. iCell Gene Therapeutics LLC
    • 14.1.15. ImmunityBio, Inc. by NantWorks LLC
    • 14.1.16. Innate Pharma S.A.
    • 14.1.17. Kiadis Pharma N.V. by Sanofi S.A.
    • 14.1.18. Merck KGaA
    • 14.1.19. MiNK Therapeutics, Inc.
    • 14.1.20. Multimmune GmbH
    • 14.1.21. Nkarta, Inc.
    • 14.1.22. PersonGen BioTherapeutics
    • 14.1.23. Phio Pharmaceuticals Inc.
    • 14.1.24. Regeneron Pharmaceuticals Inc.
    • 14.1.25. Takeda Pharmaceutical Company Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NATURAL KILLER CELL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NATURAL KILLER CELL THERAPEUTICS MARKET DYNAMICS
  • FIGURE 7. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
  • FIGURE 8. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2023 VS 2030 (%)
  • FIGURE 10. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NATURAL KILLER CELL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. NATURAL KILLER CELL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NATURAL KILLER CELL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 6. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK CELL DIRECTED ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 9. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY BISPECIFIC ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ACUTE INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY IMMUNOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. NATURAL KILLER CELL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. NATURAL KILLER CELL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. NATURAL KILLER CELL THERAPEUTICS MARKET LICENSE & PRICING